APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Granulysin (GNLY)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Granulysin (GNLY) Market Outlook and Growth Opportunities 2026

Report ID 17399630042 January 2026193 pages

Choose your research edition.

Industry ResearchGranulysin (GNLY) Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Granulysin (GNLY) Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Granulysin (GNLY) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Granulysin (GNLY) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Granulysin (GNLY) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Granulysin (GNLY) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Granulysin (GNLY) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Granulysin (GNLY) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Granulysin (GNLY) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Granulysin (GNLY) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Granulysin (GNLY) market include BD Biosciences, BioLegend, Proteintech Group, Merck KGaA and Thermofisher Scienific, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Granulysin (GNLY) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Granulysin (GNLY) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Granulysin (GNLY) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Granulysin (GNLY) market.

Granulysin (GNLY) Segment by Company

BD Biosciences

BioLegend

Proteintech Group

Merck KGaA

Thermofisher Scienific

Granulysin (GNLY) Segment by Type

9 KDa GNLY

15 KDa GNLY

Granulysin (GNLY) Segment by Application

Medical Science

Experiment

Other

Granulysin (GNLY) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Granulysin (GNLY) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Granulysin (GNLY) key companies, revenue, market share, and recent developments.

3. To split the Granulysin (GNLY) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Granulysin (GNLY) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Granulysin (GNLY) significant trends, drivers, influence factors in global and regions.

6. To analyze Granulysin (GNLY) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granulysin (GNLY) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Granulysin (GNLY) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granulysin (GNLY).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Granulysin (GNLY) industry.

Chapter 3: Detailed analysis of Granulysin (GNLY) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Granulysin (GNLY) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Granulysin (GNLY) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Granulysin (GNLY) Industry Trends Table 2. Granulysin (GNLY) Industry Drivers Table 3. Granulysin (GNLY) Industry Opportunities and Challenges Table 4. Granulysin (GNLY) Industry Restraints Table 5. Global Granulysin (GNLY) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Granulysin (GNLY) Revenue Share by Company (2021-2026) Table 7. Global Granulysin (GNLY) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Granulysin (GNLY) Key Company Manufacturing Base & Headquarters Table 9. Global Granulysin (GNLY) Company, Product Type & Application Table 10. Global Granulysin (GNLY) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Granulysin (GNLY) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of 9 KDa GNLY Table 15. Significant Companies of 15 KDa GNLY Table 16. Global Granulysin (GNLY) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Granulysin (GNLY) Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Granulysin (GNLY) Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Granulysin (GNLY) Sales Value Share by Type (2021-2026) Table 20. Global Granulysin (GNLY) Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Medical Science Table 22. Significant Companies of Experiment Table 23. Significant Companies of Other Table 24. Global Granulysin (GNLY) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Granulysin (GNLY) Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Granulysin (GNLY) Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Granulysin (GNLY) Sales Value Share by Application (2021-2026) Table 28. Global Granulysin (GNLY) Sales Value Share by Application (2027-2032) Table 29. Global Granulysin (GNLY) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Granulysin (GNLY) Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Granulysin (GNLY) Sales Value Share by Region (2021-2026) Table 32. Global Granulysin (GNLY) Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Granulysin (GNLY) Sales Value Share by Region (2027-2032) Table 34. Global Granulysin (GNLY) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Granulysin (GNLY) Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Granulysin (GNLY) Sales Value Market Share by Country (2021-2026) Table 37. Global Granulysin (GNLY) Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Granulysin (GNLY) Sales Value Market Share by Country (2027-2032) Table 39. BD Biosciences Company Information Table 40. BD Biosciences Business Overview Table 41. BD Biosciences Granulysin (GNLY) Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. BD Biosciences Granulysin (GNLY) Product Portfolio Table 43. BD Biosciences Recent Development Table 44. BioLegend Company Information Table 45. BioLegend Business Overview Table 46. BioLegend Granulysin (GNLY) Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. BioLegend Granulysin (GNLY) Product Portfolio Table 48. BioLegend Recent Development Table 49. Proteintech Group Company Information Table 50. Proteintech Group Business Overview Table 51. Proteintech Group Granulysin (GNLY) Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Proteintech Group Granulysin (GNLY) Product Portfolio Table 53. Proteintech Group Recent Development Table 54. Merck KGaA Company Information Table 55. Merck KGaA Business Overview Table 56. Merck KGaA Granulysin (GNLY) Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Merck KGaA Granulysin (GNLY) Product Portfolio Table 58. Merck KGaA Recent Development Table 59. Thermofisher Scienific Company Information Table 60. Thermofisher Scienific Business Overview Table 61. Thermofisher Scienific Granulysin (GNLY) Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Thermofisher Scienific Granulysin (GNLY) Product Portfolio Table 63. Thermofisher Scienific Recent Development Table 64. Research Programs/Design for This Report Table 65. Authors List of This Report Table 66. Secondary Sources Table 67. Primary Sources List of Figures Figure 1. Granulysin (GNLY) Product Image Figure 2. Global Granulysin (GNLY) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Granulysin (GNLY) Market Size (2021-2032) & (US$ Million) Figure 4. Global Granulysin (GNLY) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. 9 KDa GNLY Image Figure 8. 15 KDa GNLY Image Figure 9. Global Granulysin (GNLY) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Granulysin (GNLY) Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Granulysin (GNLY) Sales Value Share by Type (2021-2032) Figure 12. Medical Science Image Figure 13. Experiment Image Figure 14. Other Image Figure 15. Global Granulysin (GNLY) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Granulysin (GNLY) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Granulysin (GNLY) Sales Value Share by Application (2021-2032) Figure 18. Global Granulysin (GNLY) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Granulysin (GNLY) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Granulysin (GNLY) Sales Value (2021-2032) & (US$ Million) Figure 21. North America Granulysin (GNLY) Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Granulysin (GNLY) Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Granulysin (GNLY) Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Granulysin (GNLY) Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Granulysin (GNLY) Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Granulysin (GNLY) Sales Value (2021-2032) & (US$ Million) Figure 27. South America Granulysin (GNLY) Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Granulysin (GNLY) Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Granulysin (GNLY) Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Granulysin (GNLY) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • 9 KDa GNLY
  • 15 KDa GNLY
Applications
  • Medical Science
  • Experiment
  • Other
Companies covered
  • BD Biosciences
  • BioLegend
  • Proteintech Group
  • Merck KGaA
  • Thermofisher Scienific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Granulysin (GNLY) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Granulysin (GNLY) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Granulysin (GNLY) Market Dynamics
  1. 2.1 Granulysin (GNLY) Industry Trends
  2. 2.2 Granulysin (GNLY) Industry Drivers
  3. 2.3 Granulysin (GNLY) Industry Opportunities and Challenges
  4. 2.4 Granulysin (GNLY) Industry Restraints
3 Granulysin (GNLY) Market by Company
  1. 3.1 Global Granulysin (GNLY) Company Revenue Ranking in 2025
  2. 3.2 Global Granulysin (GNLY) Revenue by Company (2021-2026)
  3. 3.3 Global Granulysin (GNLY) Company Ranking (2024-2026)
  4. 3.4 Global Granulysin (GNLY) Company Manufacturing Base and Headquarters
  5. 3.5 Global Granulysin (GNLY) Company Product Type and Application
  6. 3.6 Global Granulysin (GNLY) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Granulysin (GNLY) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Granulysin (GNLY) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Granulysin (GNLY) Market by Type
  1. 4.1 Granulysin (GNLY) Type Introduction
  2. 4.1.1 9 KDa GNLY
  3. 4.1.2 15 KDa GNLY
  4. 4.2 Global Granulysin (GNLY) Sales Value by Type
  5. 4.2.1 Global Granulysin (GNLY) Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Granulysin (GNLY) Sales Value by Type (2021-2032)
  7. 4.2.3 Global Granulysin (GNLY) Sales Value Share by Type (2021-2032)
5 Granulysin (GNLY) Market by Application
  1. 5.1 Granulysin (GNLY) Application Introduction
  2. 5.1.1 Medical Science
  3. 5.1.2 Experiment
  4. 5.1.3 Other
  5. 5.2 Global Granulysin (GNLY) Sales Value by Application
  6. 5.2.1 Global Granulysin (GNLY) Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Granulysin (GNLY) Sales Value by Application (2021-2032)
  8. 5.2.3 Global Granulysin (GNLY) Sales Value Share by Application (2021-2032)
6 Granulysin (GNLY) Regional Value Analysis
  1. 6.1 Global Granulysin (GNLY) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Granulysin (GNLY) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Granulysin (GNLY) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Granulysin (GNLY) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Granulysin (GNLY) Sales Value (2021-2032)
  7. 6.3.2 North America Granulysin (GNLY) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Granulysin (GNLY) Sales Value (2021-2032)
  10. 6.4.2 Europe Granulysin (GNLY) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Granulysin (GNLY) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Granulysin (GNLY) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Granulysin (GNLY) Sales Value (2021-2032)
  16. 6.6.2 South America Granulysin (GNLY) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Granulysin (GNLY) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Granulysin (GNLY) Sales Value Share by Country, 2025 VS 2032
7 Granulysin (GNLY) Country-level Value Analysis
  1. 7.1 Global Granulysin (GNLY) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Granulysin (GNLY) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Granulysin (GNLY) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Granulysin (GNLY) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Granulysin (GNLY) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Granulysin (GNLY) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Granulysin (GNLY) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BD Biosciences
  2. 8.1.1 BD Biosciences Company Information
  3. 8.1.2 BD Biosciences Business Overview
  4. 8.1.3 BD Biosciences Granulysin (GNLY) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BD Biosciences Granulysin (GNLY) Product Portfolio
  6. 8.1.5 BD Biosciences Recent Developments
  7. 8.2 BioLegend
  8. 8.2.1 BioLegend Company Information
  9. 8.2.2 BioLegend Business Overview
  10. 8.2.3 BioLegend Granulysin (GNLY) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BioLegend Granulysin (GNLY) Product Portfolio
  12. 8.2.5 BioLegend Recent Developments
  13. 8.3 Proteintech Group
  14. 8.3.1 Proteintech Group Company Information
  15. 8.3.2 Proteintech Group Business Overview
  16. 8.3.3 Proteintech Group Granulysin (GNLY) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Proteintech Group Granulysin (GNLY) Product Portfolio
  18. 8.3.5 Proteintech Group Recent Developments
  19. 8.4 Merck KGaA
  20. 8.4.1 Merck KGaA Company Information
  21. 8.4.2 Merck KGaA Business Overview
  22. 8.4.3 Merck KGaA Granulysin (GNLY) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck KGaA Granulysin (GNLY) Product Portfolio
  24. 8.4.5 Merck KGaA Recent Developments
  25. 8.5 Thermofisher Scienific
  26. 8.5.1 Thermofisher Scienific Company Information
  27. 8.5.2 Thermofisher Scienific Business Overview
  28. 8.5.3 Thermofisher Scienific Granulysin (GNLY) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Thermofisher Scienific Granulysin (GNLY) Product Portfolio
  30. 8.5.5 Thermofisher Scienific Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst